• Wirawan Adikusuma Department of Pharmacy, Faculty of Health Science, University of Muhammadiyah Mataram, Mataram 83127, Indonesia
  • Nurul Qiyaam Department of Pharmacy, Faculty of Health Science, University of Muhammadiyah Mataram, Mataram 83127, Indonesia



 Objective: Examines the effects of counseling and short messages service (SMS) as a reminder and motivation toward medication adherence improvement and controlled HbA1c levels of type 2 diabetes mellitus (T2DM) patients.

Methods: This study used a quasi-experimental method with prospective data retrieval. The subjects of this study were 40 patients with outpatient T2DM in internal disease polyclinic in West Nusa Tenggara Hospital, Indonesia. Patients who fulfilled the inclusion criteria were divided into two groups: The control group (n=20) receiving only the drug care service and the treatment group (n=20) receiving counseling and SMS reminder and motivation from the pharmacist. Data collecting was conducted using the pill count method, and HbA1c levels were taken from the medical record.

Results: The results showed that counseling and SMS as reminder and motivation by a pharmacist can improve treatment adherence significantly (p<0.05) by 11.33 ± 8.47 and can decrease HbA1c level significantly (p<0.05) of 1.32 ± 0.72 in the intervention group. There was a positive correlation between T2DM patient treatment adherence to HbA1c levels (r=0.254, p=0.023).

Conclusion: The provision of counseling and SMS as a reminder and motivation by the pharmacist can have a positive effect toward medication adherence and control of HbA1c in T2DM patients.


Keywords: Treatment adherence, HbA1c, Type 2 diabetes mellitus, Counseling, Short messages service.


1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2010;33:692.
2. International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011.
3. Badan Penelitian dan Pengembangan Kesehatan, “Riset Kesehatan Dasar,” vol. 306, 2013.
4. Aronson JK. Compliance, concordance, adherence. Br J Clin Pharmacol 2007;63:383-4.
5. Dunham PJ, Karkula JM. Effects of a pharmacy care program on adherence and outcomes. Am J Pharm Benefits 2012;4:8-14.
6. Divya S, Nadig P. Factors contributing to non-adherence to medication among Type 2 diabetes mellitus in patients attending tertiary care hospital in south India. Asian J Pharm Clin Res 2015;8:8-10.
7. Renuga E, Sr R, Rani N, Thennarasu P, Kannan G. Impact of continuous patient counselling on knowledge, attitude, and practices and medication adherence of diabetic patients attending outpatient pharmacy services. Asian J Pharm Clin Res 2016;9:364-9.
8. Adikusuma W, Qiyaam N. The effect of education through short message service (SMS) messages on diabetic patients adherence. Sci Pharm 2017;85:23.
9. Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lang T. The challenges and opportunities of conducting a clinical trial in a low resource setting: The case of the cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial. Trials 2011;12:145.
10. Saputri GZ, Darmawan E, Akrom A. Decreasing Systolic Blood Pressure Via Increase Patients Adherence By Short Text Messages (SMS) and Usual Care of Pharmacist On Ambulatory Hypertension Management at Internal Disease Polyclinic, PKU Muhammadiyah Bantul Hospital, Indonesia. Proceeding Int Saf Manag Cent Cytotoxic Reconst; 2013;pp. 27-36.
11. Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Slack LR. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol 2005;12:5-9.
12. Letchuman GR, Wan Nazaimoon WM, Wan Mohamad WB, Chandran LR, Tee GH, Jamaiyah H, et al. Prevalence of diabetes in the malaysian national health morbidity survey III 2006. Med J Malaysia 2010;65:180-6.
13. Jin J, Sklar GE, Min V, Oh S. Factors affecting therapeutic compliance : A review from the patient’s perspective. Ther Clin Risk Manag 2008;4:269-86.
14. Chung WW, Chua SS, Lai PS, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with Type 2 diabetes. Patient Prefer Adherence 2014;8:1185-94.
15. Moradi M, Mousavi S. Drug use evaluation of diabetes mellitus in non-hospitalized patients. Int J Pharm Pharm Sci 2016;8:337-41.
16. van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment : A review of reviews. BMC Health Serv Res 2007;13:1-13.
17. Hadi N, Rostami-Gooran N. Determinant factors of medication compliance in hypertensive patients of shiraz, Iran. Arch Iran Med 2004;7:292-6.
18. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, et al. Medication adherence and associated hemoglobin A1c in Type 2 diabetes. Ann Pharmacother 2004;38:1357-62.
19. Rabba AK, Aljiris WS, Ahmed NJ, Alkharfy KM. Short communication medication adherence in Type 2 diabetic patients : A study in Saudi Arabia. Int J Pharm Pharm Sci 2017;9:9-12.
654 Views | 326 Downloads
How to Cite
Adikusuma, W., and N. Qiyaam. “ADHERENCE LEVEL AND BLOOD SUGAR CONTROL OF TYPE 2 DIABETES MELLITUS PATIENTS WHO GETS COUNSELING AND SHORT MESSAGES SERVICE AS REMINDER AND MOTIVATION”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 2, Feb. 2018, pp. 219-22, doi:10.22159/ajpcr.2018.v11i2.22988.
Original Article(s)